Validity of the Kinect™ Sensor for Measuring Range of Motion in Patients Post-stroke and Healthy Test Subject

NCT05295654 | Unknown

• 1 other identifier: Kinect validity study
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this research is to investigate the validity of the Kinect™ sensor in post-stroke patients and in healthy test subjects during analytic and functional movements. Measurements will be compared with the Vicon-camera system (currently seen as the golden standard).

Conditions

Stroke; Healthy

Keywords

Kinect; Validity; Vicon

Outcome Measures

Primary Outcomes (2)

• 3D kinematic measurements lower limb

  Kinematic data (i.e. movement amplitudes of the bilateral hip, knee and ankle joint in degrees) of the lower limbs during the movements will be recorded continuously with the use of the VICON Vero 1.3 system at 100 Hz.

  through study completion, an average of 1 year

• 3D kinematic measurements upper limb

  Kinematic data (i.e. movement amplitudes of the head, neck, spine, thorax and bilateral shoulder, elbow and wrist joint in degrees) of the lower limbs during the movements will be recorded continuously with the use of the VICON Vero 1.3 system at 100 Hz.

  through study completion, an average of 1 year

Study Arms (1)

Kinect validation

EXPERIMENTAL

Kinect measurements will be compared with the vicon measurements to validate the kinect system.

Other: Kinect validation

Interventions

Kinect validation OTHER

Participants will perform several movements while both the vicon and kinect are measuring.

Kinect validation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• People post-stroke or healthy test subjects
• Language: Dutch, English or French
• Age ≥ 18
• Able to sit and stand unsupported for 30 s or more
• Able to stand up from a chair without aid of another person
• Able to signal pain, fear of discomfort
• Able to give informed consent (based on the advice of a medical doctor)
• Able to understand and perform the instructions and to answer questions

You may not qualify if:

• Concurrent orthopedic and/or musculoskeletal pathologies or disorders that may limit the range of motion (including limb amputations)
• Concurrent neurological disorders (e.g. Parkinson's Disease, Multiple Sclerosis or Amyotrophic Lateral Sclerosis)
• Persons with comorbidity that could hinder the study (e.g. unstable cardiovascular system disorders, lung disorders, severe osteoporosis)
• People with difficulties of speech and/or memory providing that instruction cannot be followed or understood adequate

Sponsors & Collaborators

• Vrije Universiteit Brussel: lead

Study Sites (1)

Brubotics Rehabilitation Research Center

Brussels, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Eva Swinnen, Prof. Ph.D

  Vrije Universiteit Brussel

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Eva Swinnen, Prof. Ph.D

CONTACT

003224774527; eva.swinnen@vub.be

Emma De Keersmaecker

CONTACT

003224774527; emma.de.keersmaecker@vub.be

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 15, 2022
• First Posted: March 25, 2022
• Study Start: April 14, 2022
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: October 19, 2022

Record last verified: 2022-10

Locations

BE (1)